|Change on Regimen
May 30, 2003
Due to drugs resistance, my drugs regimen were changed to AZT, 3TC, and Stocrin around Sep 1998.
The latest Lab test of VL and CD4 on 23 Feb 2003 were 282 and 497. Before these, they were <50 and 460, respectively.
I will check VL and CD4 on 20 JUn 2003.
In case of drugs resistance, in your opinion, what drugs shall be recommended.
I don't like to take Protease Inhibitor in order to prevent Coronary Heart Disease. If I can choose.
Thanking you in advance
Upto now, I am still on AZT, 3TC, and Stocrin.
Response from Dr. Henry
The link between protease inhibitor and heart disease is unclear. Atazanavir will soon be available which is a two pill once a day protease inhibitor with little impact on lipid levels. That might be a good option to add to your regimen. You likely have some modest degree of NRTI resistance with at least the M184V mutation (3TC). Adding tenofovir and/or abacavir is a good option depending on other details of your situation. If you added those drugs your regimen would be Trizivir (AZT + 3TC + abacavir) + Stocrine + Viread= 4 pills total and would still save PIs for later use. KH
Sun sensitivity and multiple skin problems
life is for the living.
- What Percent Of The World Has Herpes?
- What Kind Of Skin Problems Can You Have If You Have Gonorrhea?
- What Can I Do To Ease The Pain From Genital Herpes?
- What Are The Different Types Of Herpes Zosters Or Shingles?
- What Is The Quickest Way To Get Rid Of Genital Warts?
- Symptoms Of Advanced Gonorrhea
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.